CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Decrease in Unrecognized Tax Benefits is Reasonably Possible
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Decrease in Unrecognized Tax Benefits is Reasonably Possible of $7.50 million as of 2025-09-27, per its 10-Q filed 2025-11-05.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible · last filed 2025-11-05
- 2025-09-27: Decrease in Unrecognized Tax Benefits is Reasonably Possible $7.50M.
- 2025-06-28: Decrease in Unrecognized Tax Benefits is Reasonably Possible $8.30M.
- 2025-03-29: Decrease in Unrecognized Tax Benefits is Reasonably Possible $8.90M.
- 2024-12-28: Decrease in Unrecognized Tax Benefits is Reasonably Possible $7.50M.
| Period end | Decrease in Unrecognized Tax Benefits is Reasonably Possible |
|---|---|
| 2025-09-27 | $7.50M 10-Q · filed 2025-11-05 |
| 2025-06-28 | $8.30M 10-Q · filed 2025-08-06 |
| 2025-03-29 | $8.90M 10-Q · filed 2025-05-07 |
| 2024-12-28 | $7.50M 10-K · filed 2025-02-19 |
| 2024-09-28 | $5.10M 10-Q · filed 2024-11-06 |
| 2024-06-29 | $5.00M 10-Q · filed 2024-08-07 |
| 2024-03-30 | $5.00M 10-Q · filed 2024-05-09 |
| 2023-12-30 | $5.20M 10-K · filed 2024-02-14 |
| 2023-09-30 | $4.00M 10-Q · filed 2023-11-08 |
| 2023-07-01 | $4.00M 10-Q · filed 2023-08-09 |
| 2023-04-01 | $4.00M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $500.00K 10-K · filed 2023-02-22 |
| 2022-09-24 | $10.60M 10-Q · filed 2022-11-02 |
| 2022-06-25 | $11.40M 10-Q · filed 2022-08-03 |
| 2022-03-26 | $11.30M 10-Q · filed 2022-05-04 |
| 2021-12-25 | $10.00M 10-K · filed 2022-02-16 |
| 2021-09-25 | $9.80M 10-Q · filed 2021-11-03 |
| 2021-06-26 | $1.10M 10-Q · filed 2021-08-04 |
| 2021-03-27 | $1.00M 10-Q · filed 2021-05-04 |
| 2020-12-26 | $2.00M 10-K · filed 2021-02-17 |
| 2020-09-26 | $1.00M 10-Q · filed 2020-10-29 |
| 2020-06-27 | $1.40M 10-Q · filed 2020-08-05 |
| 2020-03-28 | $3.00M 10-Q · filed 2020-05-07 |
| 2019-12-28 | $4.00M 10-K · filed 2020-02-11 |
| 2019-09-28 | $1.60M 10-Q · filed 2019-11-06 |
| 2019-06-29 | $8.50M 10-Q · filed 2019-07-31 |
| 2019-03-30 | $8.20M 10-Q · filed 2019-05-07 |
| 2018-12-29 | $7.60M 10-K · filed 2019-02-13 |
| 2018-09-29 | $8.20M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $700.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.90M 10-Q · filed 2018-05-10 |
| 2017-12-30 | $1.00M 10-K · filed 2018-02-13 |
| 2017-09-30 | $900.00K 10-Q · filed 2017-11-09 |
| 2017-07-01 | $5.00M 10-Q · filed 2017-08-09 |
| 2017-04-01 | $5.00M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $4.60M 10-K · filed 2017-02-14 |
| 2016-09-24 | $3.50M 10-Q · filed 2016-11-02 |
| 2016-06-25 | $3.00M 10-Q · filed 2016-08-03 |
| 2016-03-26 | $3.10M 10-Q · filed 2016-05-04 |
| 2015-12-26 | $1.90M 10-K · filed 2016-02-12 |
| 2015-09-26 | $400.00K 10-Q · filed 2015-11-04 |
| 2015-06-27 | $200.00K 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |